secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROCEPT BioRobotics Corp (PRCT)
CIK:        0001588978
Form:       8-K
Filed at:   2026-04-29T23:59:59+00:00
Accession:  0001588978-26-000020
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud

PROCEPT BioRobotics Reports Q1 2026 Revenue of $83.1M, Up 20% YoY; Net Loss Widens to $31.6M
--------------------------------------------------------------------------------

- Total revenue $83.1M, +20% YoY; U.S. procedures 12,200, +30% YoY.
- Sold 49 U.S. Hydros systems, ASP ~$485,000; U.S. install base 765 systems, +40% YoY.
- FDA clearance of second-generation FirstAssist AI software for Aquablation therapy.
- Full-year 2026 revenue guidance $390M-$410M, growth 27%-33%; adjusted EBITDA loss outlook $30M-$17M.
- Net loss $31.6M vs $24.7M in prior year; adjusted EBITDA loss $18.1M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1588978/000158897826000020/0001588978-26-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1588978/000158897826000020/prct-20260429.htm
  HTML page:      https://secwatch.observer/filing/0001588978-26-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer